This inventor holds 8 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Institut Pasteur De Lille, National Institute of Health and Medical Research, Universite Droit Et Sante Lille Ii. Active years: 2003-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lille, FR (2003)
- Wannehain, FR (2015)
- Blandain, BE (2015 - 2022)
Company Filing History:


Years Active: 2003-2022
Title: **Nathalie Mielcarek: Innovator in Vaccine Development**
Introduction
Nathalie Mielcarek, an accomplished inventor based in Blandain, Belgium, has made significant contributions to the field of immunology with her groundbreaking research and inventions. With a total of eight patents to her name, Mielcarek's work focuses on the development of innovative solutions for the prevention and treatment of infections.
Latest Patents
Among her latest patents, Mielcarek has developed an attenuated strain comprising a mutated ptx gene, a deleted or mutated dnt gene, and a heterologous ampG gene. This mutated strain is designed to be utilized in an immunogenic composition or vaccine aimed at treating or preventing infections. These innovations also include methods for protecting mammals against infection, showcasing her commitment to advancing medical science and health.
Career Highlights
Mielcarek has been associated with the Institut Pasteur De Lille, where her research has contributed to pivotal advancements in vaccine development. Her career reflects a profound dedication to innovation in the realm of infectious disease prevention and control.
Collaborations
Throughout her career, Mielcarek has collaborated with notable colleagues such as Camille Locht and Anne-Sophie Debrie. These collaborations reflect her ability to work alongside other leading experts in the field, further enhancing her contributions to science.
Conclusion
Nathalie Mielcarek stands out as a prominent figure in the field of vaccinations and immunology. Her eight patents underscore her innovative spirit and commitment to improving health outcomes through research and development. As the landscape of medical science continues to evolve, Mielcarek's contributions will undoubtedly play a crucial role in the fight against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile